We are live on ! Find out more
AVIR icon

Atea Pharmaceuticals
AVIR

127 hedge funds and large institutions have $323M invested in Atea Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 39 increasing their positions, 38 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

170% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 10

59% more capital invested

Capital invested by funds: $203M → $323M (+$119M)

14% more funds holding

Funds holding: 111 → 127 (+16)

2.47% more ownership

Funds ownership: 72.96% → 75.43% (+2.5%)

3% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 38

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
127
Holders Change
+16
Holders Change %
+14.41%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
27
Increased
39
Reduced
38
Closed
10
Calls
$612K
Puts
–
Net Calls
+$612K
Net Calls Change
+$602K

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.4M
2
RA
Rosalind Advisors
Ontario, Canada
+$5.38M
3
Two Sigma Investments
Two Sigma Investments
New York
+$5.14M
4
ICM
Irenic Capital Management
New York
+$1.39M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$1.28M

Top Sellers

1
BCM
BML Capital Management
Indiana
-$1.98M
2
JP Morgan Chase
JP Morgan Chase
New York
-$1.87M
3
Millennium Management
Millennium Management
New York
-$1.6M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$853K
5
PLC
Peapod Lane Capital
New York
-$745K
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
51
AllianceBernstein
Tennessee
$433K -$29.9K -6,500 -5%
NAMI
52
Nomura Asset Management International
Pennsylvania
$377K – – –
Deutsche Bank
53
Deutsche Bank
Germany
$353K +$59.6K +12,972 +25%
AA
54
ALPS Advisors
Colorado
$349K +$3.25K +708 +1%
Wellington Management Group
55
Wellington Management Group
Massachusetts
$307K -$853K -185,831 -77%
SPS
56
Susquehanna Portfolio Strategies
Pennsylvania
$299K +$255K +55,487 New
Squarepoint
57
Squarepoint
New York
$296K +$164K +35,787 +185%
Creative Planning
58
Creative Planning
Kansas
$279K +$127K +27,712 +115%
EF
59
Empowered Funds
Pennsylvania
$266K +$227K +49,469 New
Citadel Advisors
60
Citadel Advisors
Florida
$260K +$26.2K +5,710 +13%
RC
61
Rangeley Capital
Connecticut
$250K -$154K -33,500 -42%
AQR Capital Management
62
AQR Capital Management
Connecticut
$248K +$146K +31,811 +222%
Jacobs Levy Equity Management
63
Jacobs Levy Equity Management
New Jersey
$232K – – –
MIM
64
MetLife Investment Management
New Jersey
$214K +$46.2K +10,060 +34%
VF
65
Virtu Financial
New York
$183K +$156K +34,030 New
Mirae Asset Global ETFs Holdings
66
Mirae Asset Global ETFs Holdings
Hong Kong
$182K +$3.56K +776 +2%
NCNMGF
67
Nano-Cap New Millennium Growth Fund
New York
$175K -$80.4K -17,500 -35%
RC
68
RBF Capital
California
$161K – – –
Russell Investments Group
69
Russell Investments Group
United Kingdom
$148K +$61.3K +13,340 +91%
Wells Fargo
70
Wells Fargo
California
$144K -$244K -53,025 -66%
VGA
71
Vanguard Global Advisers
Pennsylvania
$138K +$118K +25,681 New
CAC
72
Certified Advisory Corp
Florida
$132K – – –
XT
73
XTX Topco
Cayman Islands
$124K +$58.3K +12,702 +122%
State Board of Administration of Florida Retirement System
74
State Board of Administration of Florida Retirement System
Florida
$118K – – –
Manulife (Manufacturers Life Insurance)
75
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$109K -$17.4K -3,795 -16%
1 2
3
4 5

AVIR Hedge Fund Activity: Q1 2026 in Review

127 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Atea Pharmaceuticals (AVIR) for Q1 2026, worth a combined $323M — up 59% from $203M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new AVIR positions and 10 closed out — a net gain of 17 holders — while 39 added to existing stakes and 38 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $10.4M. The largest seller was BML Capital Management, cutting an estimated $1.98M.

  • 127 institutional investors held Atea Pharmaceuticals (AVIR) as of Q1 2026, up from 111 in Q4 2025.
  • Funds reported $323M of Atea Pharmaceuticals stock for Q1 2026, up 59% quarter-over-quarter.
  • 27 funds opened new Atea Pharmaceuticals positions in Q1 2026 and 10 closed out, a net change of +17 holders.
  • The largest Atea Pharmaceuticals buyer in Q1 2026 was Fidelity Investments, an estimated $10.4M added.
  • The largest Atea Pharmaceuticals seller in Q1 2026 was BML Capital Management, an estimated $1.98M sold.

Based on aggregated 13F filings for Q1 2026.